| Galapagos Diversifies into Antibodies |
Abstract
html
|
|
Sally Mardikian PhD |
|
| Cephalon Signs Option Agreement for ImmuPharma’s First-in-class Lupus Drug |
Abstract
pdf
html
|
|
Helen Scrutton |
|
| Merrion to Develop Insulin Drugs with Novo |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Cash-strapped TorreyPines Divests its Alzheimer’s Disease Developments |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| XOMA Makes Cost-Cutting Move by Restructuring Novartis Deal |
Abstract
pdf
html
|
|
Helen Scrutton |
|
| Eli Lilly Steps Up Pharmacogenetics Effort |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
| Genzyme and Osiris Sign Deal for First-in-Class Adult Stem Cell Products |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| Johnson & Johnson Strengthens its Biosurgical Position by Acquiring Omrix |
Abstract
pdf
html
|
|
Sally Mardikian PhD |
|
| NitroMed and Archemix Sign Reverse Merger Deal |
Abstract
pdf
html
|
|
Helen Scrutton |
|
| Zydus Cadila Enters Vaccines Market by Acquiring Etna Biotech |
Abstract
pdf
html
|
|
Taskin Ahmed |
|
| The Rebirth of Regenerative Medicine |
Abstract
html
|
|
Fintan Walton |
|
